Clinical trial
Fenofibrate and Metformin Insulin Sensitivity in Type 2 Diabetics Study
NCT00362765 · Solvay Pharmaceuticals, Industry · Terminated
Key facts
| NCT number | NCT00362765 |
|---|---|
| Title | Fenofibrate and Metformin Insulin Sensitivity in Type 2 Diabetics Study |
| Official title | Assessment of Insulin Sensitivity in Type 2 Diabetics Treated With Metformin, Fenofibrate and Their Combination. |
| Lead sponsor | Solvay Pharmaceuticals, Industry |
| Status | Terminated |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes, Dyslipidemia |
| Intervention type | Drug |
| Interventions | Fenofibrate, Metformin, Placebo |
| Enrollment | 8 |
| Start date | Oct 1, 2006 |
| Completion | Jul 1, 2007 |
| First posted | Aug 10, 2006 |
| Last update posted | Aug 13, 2008 |
| Countries | Finland, Ireland, Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: